Development of a DNA-based lung cancer vaccine in the United Kingdom received funding for 2 years of laboratory research and initial manufacture of 3000 doses, according to a press release from the ...

Cancer vaccines have long sounded like science fiction, but a new wave of nanoparticle research is pushing that idea closer to everyday reality. By packaging tumor signals into tiny, engineered ...